Open Access<p>Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients</p>
Author(s) -
Anna Pawłowska,
Dorota Suszczyk,
Rafał Tarkowski,
Roman Paduch,
Jan Kotarski,
Iwona Wertel
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s263010
Subject(s) - biomarker , ovarian cancer , medicine , oncology , cancer research , cancer , chemistry , biochemistry
Ovarian cancer (OC) is one of the most lethal gynecological malignancies. Recent studies suggest a crucial role of the PD-1/PD-L1 pathway in OC pathogenesis. Therefore, our study aimed at evaluation of the clinical importance of PD-1 expression in ovarian cancer patients.